Tokuyama is engaged in the manufacture and sale of chemicals, specialty products, cement and functional materials. Co.'s principal products include soda ash, calcium chloride, sodium silicate, caustic soda, vinyl chloride monomer, propylene oxide, methylene chloride, polyvinyl chloride, polycrystalline silicon, fumed silica, aluminum nitride, high-purity chemicals, methylene chloride, polycrystalline silicon, fumed silica, aluminum nitride substrate, portland cement, cement-type soil solidifier, ready-mixed concrete, active pharmaceutical ingredients and intermediates, plastic lens-related materials, microporous film, polyolefin film, ion exchange membranes, and plastic window sashes.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
MSCI ACWI hitting multi-month highs, U.S. remains leadership Note: This week's report is presented in an abbreviated format, as we are publishing the June International Macro Vision book this week (available next Tues. AM). Over the past several weeks we have outlined the case for our increasingly bullish outlook, noting that market internals remain favorable and S&P 500 and MSCI ACWI price trends are showing evidence of early-stage uptrend formations. In today's report we provide an overview of international markets and highlight our top recommendations. • Index overviews. Led by U.S. outp...
Not much has changed over the past week when looking at the MSCI ACWI and S&P 500, with prices generally trending sideways and no material changes in our primary breadth indicators. Therefore, our outlook remains positive given breadth and price action improvements on both the ACWI and S&P 500 relative to mid-April (both developments that we highlighted in the 5/17/18 International Compass). • Major themes: Opportunities within Health Care and Materials. Price and relative strength trends continue to improve for our international equal-weight Health Care Sector. We recommend adding exposure.....
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...
CLICKS GROUP LIMITED (ZA), a company active in the Drug Retailers industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date November 12, 2019, the closing price was ZAR 253.90 and its potential was estimated at ZAR 269.63.
NETCARE LTD. (ZA), a company active in the Health Care Providers industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 2 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date November 12, 2019, the closing price was ZAR 16.83 and its expected value was estimated at ZAR 17.28.
The independent financial analyst theScreener just awarded an improved star rating to WESCO INTL.INCO. (US), active in the Electrical Components & Equipment industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 4 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date November 12, 2019, the closing price was USD 54.52 and its expected value was estimated at USD 48.88.
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.